| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790008 | Urologic Oncology: Seminars and Original Investigations | 2018 | 13 Pages |
Abstract
Importin-11 overexpression can promote BCa cell invasiveness, probably associated with the deregulation of CDKN1A and THBS1 primarily through the activation of the proteoglycans in cancer pathway and the classical BCa pathway. Importin-11 may be a useful target through which the progression of noninvasive BCa to invasive BCa can be blocked.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Junjie M.D., Lei M.D., Shuxiong M.D., Chong M.D., Weidong M.D., Zhensheng M.D., Qingzuo M.D., Peng M.D., Yinghao M.D., Chuanliang M.D.,